Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.03 USD | -12.96% | -52.90% | -55.64% |
May. 17 | Jaguar Health Plans 1-for-60 Reverse Split Next Week | MT |
May. 14 | Earnings Flash (JAGX) JAGUAR HEALTH Reports Q1 Revenue $2.4M, vs. Street Est of $3M | MT |
Financials (USD)
Sales 2024 * | 15.11M | Sales 2025 * | 22.66M | Capitalization | 22.64M |
---|---|---|---|---|---|
Net income 2024 * | -26M | Net income 2025 * | -21M | EV / Sales 2024 * | 1.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1 x |
P/E ratio 2024 * |
-0.75
x | P/E ratio 2025 * |
-0.96
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.62% |
Latest transcript on Jaguar Health, Inc.
1 day | -12.96% | ||
1 week | -60.16% | ||
Current month | -68.72% | ||
1 month | -62.69% | ||
3 months | +16.00% | ||
6 months | -80.79% | ||
Current year | -55.64% |
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 19-04-30 |
Chief Tech/Sci/R&D Officer | 60 | 17-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 13-06-05 |
James Bochnowski
CHM | Chairman | 80 | 14-01-31 |
John Micek
BRD | Director/Board Member | 71 | 16-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 4.03 | -12.96% | 1,350,614 |
24-05-24 | 4.63 | -9.75% | 1,203,516 |
24-05-23 | 5.13 | -33.26% | 1,316,768 |
24-05-22 | 7.686 | -10.17% | 552,511 |
24-05-21 | 8.556 | -15.42% | 552,731 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.64% | 22.64M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- JAGX Stock